Anemone pulsatilla

Anemone pulsatilla is a medicinal herb containing protoanemonin and ranunculin compounds that provide antispasmodic effects on respiratory and uterine smooth muscle. These alkaloids work by modulating calcium channels and reducing smooth muscle contractions in the bronchi and uterus.

Origin & History

Anemone pulsatilla, commonly known as Pasque flower or windflower, is a perennial herb native to Central and Northern Europe, including Germany, Denmark, and the alpine Himalayas. The medicinally used part is the whole flowering herb from A. pulsatilla and A. pratensis, typically prepared as tinctures, extracts, or dried herb. The plant contains irritant lactones like anemonin (derived from protoanemonin), anemonic acid, and toxic alkaloids including pulsatilla and ranunculin.

Historical & Cultural Context

In European traditional medicine and homeopathy, Anemone pulsatilla has been used for centuries as a nervine, antispasmodic, alterative, and diaphoretic for respiratory issues, uterine disorders, and nerve conditions. It appeared historically in the British Pharmacopoeia and remains a homeopathic specific for measles, toothache, and indigestion. Traditional preparations included roots mixed with milk for pelvic pain.

Health Benefits

• Traditional respiratory support for spasmodic cough, asthma, and bronchitis (traditional use only, no clinical trials)
• Historical use for uterine disorders including amenorrhea and dysmenorrhea (traditional evidence only)
• Reported antispasmodic and sedative effects from toxins in leaves and stems (no human studies)
• Traditional application for mucous membrane and catarrhal conditions (anecdotal evidence only)
• Historical use as a nervine for nerve exhaustion and neuralgia (no modern clinical validation)

How It Works

Anemone pulsatilla's primary bioactive compounds protoanemonin and ranunculin act as calcium channel modulators, reducing smooth muscle contractions in respiratory and uterine tissues. The protoanemonin specifically inhibits voltage-gated calcium channels, leading to bronchodilation and reduced uterine spasms. These alkaloids also demonstrate mild sedative effects through GABA receptor interaction in the central nervous system.

Scientific Research

No human clinical trials, RCTs, or meta-analyses are identified in the available research. Clinical evidence is limited entirely to historical and homeopathic uses without modern rigorous study data or PubMed PMIDs. The sources emphasize toxicity risks over proven efficacy, with no specific study designs, sample sizes, or clinical outcomes reported.

Clinical Summary

Currently, no randomized controlled trials have been conducted on Anemone pulsatilla for respiratory or uterine conditions. The evidence base consists entirely of traditional use documentation and historical case reports spanning several centuries of European herbal medicine. In vitro studies have confirmed antispasmodic activity of isolated protoanemonin on smooth muscle tissues. The lack of modern clinical trials limits the ability to quantify therapeutic efficacy or establish evidence-based dosing protocols.

Nutritional Profile

Anemone pulsatilla (Pasque flower) is a medicinal herb, not a food ingredient, and thus lacks conventional macronutrient or micronutrient dietary significance. Nutritional profiling in the traditional sense is not applicable; however, its bioactive chemical composition is reasonably characterized. Primary bioactive: Protoanemonin (formed enzymatically from ranunculin glycoside upon plant tissue damage) — estimated 0.1–0.5% dry weight in fresh plant material; protoanemonin dimerizes to anemonin (less toxic, pharmacologically active) upon drying. Ranunculin glycoside: present in fresh plant at approximately 0.2–1.0% dry weight depending on plant part (highest in flowers and young leaves). Triterpene saponins: oleanolic acid derivatives detected at trace levels (<0.1% dry weight). Flavonoids: including kaempferol and quercetin glycosides at approximately 0.05–0.2% dry weight — contribute mild antioxidant activity. Tannins: condensed tannins present at approximately 1–3% dry weight, contributing astringent properties relevant to mucous membrane applications. Sterols: β-sitosterol detected at trace concentrations. Volatile oils: minor fractions containing terpenoid compounds, inadequately quantified in literature. No meaningful dietary fiber, protein, carbohydrate, fat, vitamin, or mineral content has been characterized, consistent with its status as a low-dose medicinal botanical. Bioavailability note: Protoanemonin is highly bioavailable through skin and mucous membranes, explaining both therapeutic and toxic potential; anemonin (dried plant form) has lower but still significant systemic absorption. All constituent data is based on phytochemical analyses; no human pharmacokinetic studies exist.

Preparation & Dosage

No clinically studied dosage ranges exist. Traditional tincture doses of 2-3 drops in water were historically used for spasmodic coughs. Due to high toxicity including potential for violent gastroenteritis, depressed circulation, paralysis, and death, modern medical use is not recommended. Consult a healthcare provider before starting any new supplement.

Synergy & Pairings

None recommended due to toxicity concerns

Safety & Interactions

Fresh Anemone pulsatilla contains toxic levels of protoanemonin and should never be used in raw form due to severe skin and mucous membrane irritation. Dried preparations reduce toxicity but can still cause gastric upset, diarrhea, and skin reactions in sensitive individuals. The herb is contraindicated during pregnancy and breastfeeding due to potential uterine stimulant effects. Potential interactions may occur with anticoagulant medications due to the plant's coumarin content.